Welcome to the MRSA Initiative

Addressing the challenges in the management and treatment of Methicillin-Resistant Staphylococcus Aureus

In considering the overall issue of Methicillin-resistant Staphylococcus aureus (MRSA) within North America and around the world, the American Society for Microbiology (ASM) has carefully noted the segments within the overall issue where additional/new information would serve to improve the overall understanding of MRSA and its true impact on patients, the medical community and society in general. Understanding that local, regional and national resources for addressing MRSA can vary around the globe, the ASM is focused on presenting a range of options within each key element of the MRSA Initiative (MRSA-I).  

This program has been established to focus on the complex and critical issues related to MRSA facing the medical community and the population as a whole. The structure and content of this initiative has been developed based on the needs assessment data compiled by the ASM, corroborated via the program faculty and additional supporting research.


Organized by:
MRSA Initiative
ASM wishes to recognize Astellas Pharma, US, Inc., for providing an educational grant to support MRSA-I